SGN-00101

A recombinant chimeric protein composed of the heat shock protein 65 (Hsp65) from Mycobacterium bovis, and the human papilloma viral (HPV) protein E7… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2006
0120012006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
OBJECTIVE Approximately 2 million women worldwide are infected with high-risk human papillomaviruses (HPV), resulting in a… (More)
Is this relevant?
2007
2007
OBJECTIVES SGN-00101 (HspE7, Nventa, San Diego, CA) is a novel therapeutic vaccine consisting of a fusion protein containing an M… (More)
Is this relevant?
2006
2006
OBJECTIVES To test a therapeutic vaccine consisting of a fusion of the human papillomavirus (HPV) 16 E7 protein and the… (More)
Is this relevant?
2001
2001
  • Sevgin Hunt
  • Current opinion in molecular therapeutics
  • 2001
StressGen is developing HspE7 (SGN-00101) as a potential therapy for human papillomavirus (HPV)-associated conditions. It is a… (More)
Is this relevant?